Cresset releases Flare™ V10, the latest update to its agile ligand and structure-based drug design platform, featuring significant scientific enhancements for computational and medicinal chemists
12th February 2025 – Cambridge, UK – Cresset, a leading provider of integrated in silico solutions for small molecule drug discovery announces the release of its Flare platform V10, bringing enhanced scientific features for both computational and medical chemists.
The benefits and challenges of designing and installing a ducted plenum for cleanrooms
A ducted plenum is a crucial component in cleanroom design, ensuring controlled airflow, contamination prevention and compliance with strict industry regulations. While it offers many benefits, it also presents certain challenges that must be carefully considered.
Glox Therapeutics strengthens team appointing Dr Michael Murray as Chair and Dr Nel Moore as Scientific Advisory Board Member
Expanded team to support development and commercialisation of precision antibiotics to help overcome antimicrobial resistance
#21toWatch Innovation Awards 2025 shortlist is announced
The 2025 shortlist for next month’s coveted #21toWatch Awards has been announced, once again spotlighting some of the most inspirational entrepreneurs and game-changing innovations from Cambridge and across the East of England.
Green shoots in science & technology office and laboratory demand
Bidwells maintains position as the most active agency in Cambridge and secures largest transaction since 2021.
China's medical AI evolution: Insights and opportunities for UK-China collaboration in healthcare innovation
China's medical AI landscape is undergoing a significant transformation, offering valuable insights for global healthcare sectors, including the UK. The evolution from an initial "AI doctor replacement" mindset to a more nuanced "AI empowerment" approach highlights a maturing industry that prioritizes augmenting human capabilities rather than replacing them.
More North-South collaboration will strengthen disease surveillance in the UK, South Africa, and the world
The North-South partnership between the Genomic Surveillance Unit (GSU) at the Wellcome Sanger Institute and the Centre for Epidemic Response and Innovation (CERI) at Stellenbosch University (SU), has received funding under the UK Foreign, Commonwealth & Development Office’s (FCDO) UK-SA Health System Strengthening Partnership.
New 2-axis heavy-duty motorized stage series offers precision positioning for large samples
Prior Scientific launches the HT11 Series, a new range of heavy-duty motorized stages designed for whole animal imaging and industrial applications.
Equip your Life Sciences application for success with a hassle-free Guardware furniture fit-out
Haverhill contamination control specialists Guardtech Group promise to banish the stress of equipment procurement with their one-stop shop.
Proposed Delisting via Merger of BenevolentAI into Osaka Holdings S.à r.l. and Publication of Notice of Extraordinary General Meeting
London, UK, 6 February 2025: BenevolentAI, (“BenevolentAI” or “the Company”) (Euronext Amsterdam: BAI), a pioneer in AI-driven drug discovery, announces:
Cambridge Dragon Boat Festival returns on September 13, 2025 – get ready to race for a cause!
The Cambridge Dragon Boat Festival pulls in teams from Cambridgeshire and further afield - raising money for an important cause: the Cambridge Cancer Research Hospital. The event not only challenges teams and bonds them together but also provides family, fun-filled entertainment along the river bank in Fen Ditton. So if you fancy taking part, or coming along to watch this impressive festival in…
Antibodies.com and Cactus Communications partner to accelerate life science manuscript publication
Partnership provides Antibodies.com’s network of scientists with access to CACTUS’ editorial and publishing services to improve manuscript quality and increase publication success
Gyros Protein Technologies introduces Gyrolab HEK293 HCP Type SN and Type CL Kit Reagents to support biotherapeutic development
Ready-to-use kits expand portfolio of host cell protein impurity kits, for quantification of host cell proteins from HEK293 cell lines Kits developed through a collaboration with BioGenes GmbHUppsala, Sweden, 05 February 2025:
Opportunities and challenges: Insights into China's medical device market for 2025
As the global healthcare landscape evolves, China's medical device market presents a wealth of opportunities for our UK partners and clients. Despite geopolitical tensions, collaboration between the UK and China in this sector can yield mutual benefits, driving innovation and improving healthcare outcomes worldwide.
New opportunities - NIHR i4i Funding
New opportunities for innovators in medical devices, in vitro diagnostics, and digital health technologies to secure funding for projects addressing existing or emerging health and social care needs.
Sapio Sciences selected by LabConnect to transform laboratory operations
Sapio LIMS to enhance research workflows, improve data integrity, and support scalable innovation
Challenges in the diagnosis and management of Asthma in children
Asthma is a common childhood respiratory condition, affecting around 14% of children worldwide [1]. Characteristic symptoms of asthma include wheezing, shortness of breath and coughing, usually triggered by exposure to certain allergens.
Optibrium widens access to industry-leading docking method
New PyMOL interface extends access to Optibrium’s structure-based design method Surflex-Dock
CN Bio launches PhysioMimix DILI assay kit: Human 24, for enhanced preclinical toxicology testing
· All-in-one kit enables in-house, in vitro profiling of human drug-induced liver injury
Addenbrooke's hospital charity celebrates its first corporate partner to raise over half a million
Addenbrooke's Charitable Trust is the official charity for Addenbrooke's and the Rosie and helps to fund cutting edge equipment and groundbreaking research, above and beyond what the NHS is able to provide. Examples include supporters raising an impressive £1.5 million to fund a surgical robot for the hospitals which is already helping to cut waiting lists and reduce patients' recovery time…
Lessons on charisma from a Nobel Peace Prize winner
Is ‘finding more clients’ on your goals list for 2025?
Samuel Atack appointed as Operations Director at Stevenage Bioscience Catalyst
Stevenage Bioscience Catalyst are delighted to announce that Samuel Atack will be stepping into the role of Operations Director at Stevenage Bioscience Catalyst on 1st April 2025 when current Operations Director Dave Mudd retires.
Does Microsoft 365 Business Standard have everything you need to keep your organisation running smoothly?
Microsoft 365 Business Standard has all the tools you need to keep your business running smoothly.
Why your organisation needs Microsoft 365 Business Premium
If you use Microsoft 365 Business Standard, you’ll already know about the range of tools and features that help your business function better every day ....
42 Technology appoints Dr Peter Brown as Chief Commercial Officer
42 Technology (42T) has appointed Dr Peter Brown as its first Chief Commercial Officer (CCO). In this newly-created role, Peter will now oversee all global sales and business development activities and help drive the company’s expansion across its five industry sectors: consumer, energy, life sciences, medtech and industrial. He also joins the company’s board of directors with immediate effect.